189 related articles for article (PubMed ID: 7700165)
21. FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma.
Spitz R; Hero B; Ernestus K; Berthold F
Med Pediatr Oncol; 2003 Jul; 41(1):30-5. PubMed ID: 12764740
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of genetic rearrangements in human neuroblastomas.
Brodeur GM
Clin Chem; 1989 Jul; 35(7 Suppl):B38-42. PubMed ID: 2568197
[TBL] [Abstract][Full Text] [Related]
23. Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma.
Schleiermacher G; Peter M; Michon J; Hugot JP; Vielh P; Zucker JM; Magdelénat H; Thomas G; Delattre O
Genes Chromosomes Cancer; 1994 Aug; 10(4):275-81. PubMed ID: 7522542
[TBL] [Abstract][Full Text] [Related]
24. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
25. Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
Hogarty MD; Maris JM; White PS; Guo C; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):52-5. PubMed ID: 11464906
[TBL] [Abstract][Full Text] [Related]
26. Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma.
Maris JM; Guo C; White PS; Hogarty MD; Thompson PM; Stram DO; Gerbing R; Matthay KK; Seeger RC; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):24-7. PubMed ID: 11464895
[TBL] [Abstract][Full Text] [Related]
27. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.
Caron H; van Sluis P; van Hoeve M; de Kraker J; Bras J; Slater R; Mannens M; Voûte PA; Westerveld A; Versteeg R
Nat Genet; 1993 Jun; 4(2):187-90. PubMed ID: 8102298
[TBL] [Abstract][Full Text] [Related]
28. Chromosome 1p allelic loss in neuroblastoma: prognosis, genomic imprinting and 1;17 translocations.
Caron H; van Sluis P; van Roy N; Beks L; Maes P; Pereira do Tanque R; Slater R; de Kraker J; Speleman F; Voûte PA
Prog Clin Biol Res; 1994; 385():35-42. PubMed ID: 7972230
[No Abstract] [Full Text] [Related]
29. Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma.
Spitz R; Hero B; Ernestus K; Berthold F
Clin Cancer Res; 2003 Oct; 9(13):4835-40. PubMed ID: 14581355
[TBL] [Abstract][Full Text] [Related]
30. Prognostic relevance of genetic alterations in the p32 region of chromosome 1 in neuroblastoma.
Avigad S; Benyaminy H; Tamir Y; Luria D; Yaniv I; Stein J; Stark B; Zaizov R
Eur J Cancer; 1997 Oct; 33(12):1983-5. PubMed ID: 9516838
[TBL] [Abstract][Full Text] [Related]
31. PCR assay for chromosome 1p deletion in small neuroblastoma samples.
Peter M; Michon J; Vielh P; Neuenschwander S; Nakamura Y; Sonsino E; Zucker JM; Vergnaud G; Thomas G; Delattre O
Int J Cancer; 1992 Oct; 52(4):544-8. PubMed ID: 1399134
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide analysis of neuroblastomas using high-density single nucleotide polymorphism arrays.
George RE; Attiyeh EF; Li S; Moreau LA; Neuberg D; Li C; Fox EA; Meyerson M; Diller L; Fortina P; Look AT; Maris JM
PLoS One; 2007 Feb; 2(2):e255. PubMed ID: 17327916
[TBL] [Abstract][Full Text] [Related]
33. Deletion mapping of chromosome 1p and 22q in pheochromocytoma.
Shin E; Fujita S; Takami K; Kurahashi H; Kurita Y; Kobayashi T; Mori T; Nishisho I; Takai S
Jpn J Cancer Res; 1993 Apr; 84(4):402-8. PubMed ID: 8514606
[TBL] [Abstract][Full Text] [Related]
34. Chromosome 1p and 11q deletions and outcome in neuroblastoma.
Attiyeh EF; London WB; Mossé YP; Wang Q; Winter C; Khazi D; McGrady PW; Seeger RC; Look AT; Shimada H; Brodeur GM; Cohn SL; Matthay KK; Maris JM;
N Engl J Med; 2005 Nov; 353(21):2243-53. PubMed ID: 16306521
[TBL] [Abstract][Full Text] [Related]
35. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.
Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Fukuba I; Matsuura Y; Yokoyama T
Med Pediatr Oncol; 2001 Jan; 36(1):67-74. PubMed ID: 11464909
[TBL] [Abstract][Full Text] [Related]
36. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.
Cheng JM; Hiemstra JL; Schneider SS; Kaufman BA; Naumova A; Cheung NK; Cohn SL; Diller L; Sapienza C; Brodeur GM
Prog Clin Biol Res; 1994; 385():43-9. PubMed ID: 7972236
[TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity for chromosome 1p in familial neuroblastoma.
Tonini GP; Lo Cunsolo C; Cusano R; Iolascon A; Dagnino M; Conte M; Milanaccio C; De Bernardi B; Mazzocco K; Scaruffi P
Eur J Cancer; 1997 Oct; 33(12):1953-6. PubMed ID: 9516831
[TBL] [Abstract][Full Text] [Related]
38. Peculiar allelotype associated with susceptibility to neuroblastoma.
Perri P; Pession A; Mazzocco K; Strigini P; Iolascon A; Basso G; Tonini GP
Genes Chromosomes Cancer; 1996 Sep; 17(1):60-3. PubMed ID: 8889508
[TBL] [Abstract][Full Text] [Related]
39. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3.
White PS; Maris JM; Beltinger C; Sulman E; Marshall HN; Fujimori M; Kaufman BA; Biegel JA; Allen C; Hilliard C; Valentine MB; Look AT; Enomoto H; Sakiyama S; Brodeur GM
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5520-4. PubMed ID: 7777541
[TBL] [Abstract][Full Text] [Related]
40. Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity.
Caron H; van Sluis P; van Roy N; de Kraker J; Speleman F; Voûte PA; Westerveld A; Slater R; Versteeg R
Am J Hum Genet; 1994 Aug; 55(2):341-7. PubMed ID: 8037211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
